Litigation Details for HELSINN HEALTHCARE S.A. v. GLAND PHARMA LIMITED (D.N.J. 2022)
✉ Email this page to a colleague
HELSINN HEALTHCARE S.A. v. GLAND PHARMA LIMITED (D.N.J. 2022)
| Docket | ⤷ Sign Up | Date Filed | 2022-07-18 |
| Court | District Court, D. New Jersey | Date Terminated | 2022-12-23 |
| Cause | 35:271 Patent Infringement | Assigned To | Zahid Nisar Quraishi |
| Jury Demand | None | Referred To | J. Brendan Day |
| Parties | HELSINN HEALTHCARE S.A. | ||
| Patents | 10,208,073; 8,426,450; 8,623,826; 8,895,586; 9,186,357; 9,271,975; 9,403,772; 9,908,907; 9,943,515 | ||
| Attorneys | WILLIAM C. BATON | ||
| Firms | Saul Ewing LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in HELSINN HEALTHCARE S.A. v. GLAND PHARMA LIMITED
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for HELSINN HEALTHCARE S.A. v. GLAND PHARMA LIMITED (D.N.J. 2022)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2022-07-18 | 1 | Exhibits A-J | States Patent (10) Patent No.: US 10,208,073 B2 …: 158 U.S. Patent Feb. 19, 2019 US 10,208,073 B2 … US 10,208,073 B2 … US 10,208,073 B2 1 … US 10,208,073 B2 3 eroaryl | External link to document |
| 2022-10-11 | 25 | Counterclaim AND Amended Answer to Complaint | the ’772 patent”), U.S. Patent No. 9,908,907 (“the ’907 patent”), U.S. Patent No. 10,208,073 (“the ’073…,907 (“the ’907 patent”), U.S. Patent No. 10,208,073 (“the ’073 patent”), U.S. Patent No. 10,624,911 … Patent No. 9,908,907 (“the ’907 patent”), U.S. Patent No. 10,208,073 (“the ’073 patent”), U.S. Patent…’450 patent, the ’586 patent, the ’357 patent, the ’772 patent, the ’907 patent, the ’073 patent, the …’450 patent, the ’586 patent, the ’357 patent, the ’772 patent, the ’907 patent, the ’073 patent, the | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
